pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

1,179 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT786Endpoints593BioPharma Dive228onclive165BioSpace63Fierce Biotech63raps25
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6
  • STAT+: NIH cuts weakened network primed to respond to outbreaks like Ebola
    While NIH-funded centers weren’t on the front lines of virus responses like the CDC or USAID, some researchers involved in the network said the cuts have damaged relationships with experts…
    STAT · 1mo ago↗ source
  • STAT+: Trump’s Medicaid work requirements have an unwelcome surprise for some states and patients
    Advocates were already dreading Medicaid's work requirements. New rules are worse than they feared.
    STAT · 1mo ago↗ source
  • Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.
    A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country from Africa and lying about it.
← prev
page 24 of 48
next →
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
STAT · 1mo ago
↗ source
  • Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
    <figure><div><img src="https://imgproxy.divecdn.com/hbk6XyVan10rkkgfacDKrllv7E86oIa8ejytDOpzCw8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMTg0MTk0NzE1LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Eli Lilly issues data sharing ultimatum to 340B hospitals
    <figure><div><img src="https://imgproxy.divecdn.com/8nTrHlsFTcngJswJxr_8afos9dxh_YxQE6LZmgMA2_I/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDczMjEzX2VHa…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Longevity startup NewLimit raises $435 million ahead of first clinical trial
    Longevity startup NewLimit plans to launch its first clinical trial of a liver medicine after raising a staggering $435 million in new funding.
    STAT · 1mo ago↗ source
  • Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug
    <figure><div><img src="https://imgproxy.divecdn.com/NkRGM2WlVG_bih055HG7zy8PbwZNjna8pIs5Yzt_9MI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTcwOTEzMjEwLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • STAT+: Radiopharmaceutical shows promise in post-Pluvicto setting
    Abivax's ulcerative colitis data, Fulcrum's scrapped sickle cell drug, and more biotech news from The Readout
    STAT · 1mo ago↗ source
  • STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
    Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price breaks
    STAT · 1mo ago↗ source
  • AbiVax falls as safety worries cloud ‘landmark’ immune drug results
    <figure><div><img src="https://imgproxy.divecdn.com/xa_T0oT9Hj8F-wJjKfJeFkbn4Yqp_lT58dL0S4GszxY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy02MjEzNjQ4MDJfMS5qc…
    BioPharma Dive · 1mo ago↗ source
  • How one state’s medical meal program lowered health care costs
    Medicaid work requirements, fast-tracked funding for experimental Ebola vaccines, and more health news from Morning Rounds
    STAT · 1mo ago↗ source
  • ASCO ‘26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer
    <p>At the year’s biggest cancer meeting, a high-stakes clash between two popular drug classes erupted, and scientists made headway against a once-insurmountable foe.</p>
    BioPharma Dive · 1mo ago↗ source
  • Why US-manufactured pharmaceutical packaging equipment matters
    <p>As manufacturers modernize operations, the origin of their equipment is a strategic consideration.</p>
    BioPharma Dive · 1mo ago↗ source
  • Opinion: The virtual end of the doctor’s office waiting room
    It’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.
    STAT · 1mo ago↗ source
  • STAT+: Online care is caught in the crossfire as states crack down on corporate medicine
    Growing legislative scrutiny across multiple states targets the corporate structure underlying most direct-to-consumer telehealth businesses.
    STAT · 1mo ago↗ source
  • STAT+: Trump administration releases rules for new Medicaid work requirements
    States are racing to implement the new requirements by the start of next year.
    STAT · 1mo ago↗ source
  • STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
    Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next five days — or lose price breaks.
    STAT · 1mo ago↗ source
  • STAT+: Global coalition to fast-track three vaccines targeting Ebola outbreak with $62 million in funding
    With no licensed vaccines available to protect against the Ebola virus currently spreading in the Congo, efforts are underway to fast-track development of at least three vaccines.
    STAT · 1mo ago↗ source
  • STAT+: Abivax ulcerative colitis drug shows strong efficacy, but cases of cancer raise concerns
    Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but shares of the company tanked on safety concerns.
    STAT · 1mo ago↗ source
  • STAT+: At ASCO, talk of barriers to cancer care, new treatments, and other big takeaways
    Here is some of what you may have missed from the world's largest cancer research meeting.
    STAT · 1mo ago↗ source
  • STAT+: At the world’s largest cancer research meeting, data briefly took a backseat to grief
    At the world's largest cancer research meeting, new data were plentiful. But this year, there was also a focus on grief.
    STAT · 1mo ago↗ source
  • RallyBio tries again for reverse merger, this time with Avenzo
    <figure><div><img src="https://imgproxy.divecdn.com/jnFfJ5RS6xuGM4eSgKJWCwh47VZKvpGyBiu3dqhXngw/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjIwOTA5MTA5LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Servier buys into muscular dystrophy with potentially $2.7B deal
    <figure><div><img src="https://imgproxy.divecdn.com/noY6Oanv5v-_yDQZKEqBBDkEKvecYGoj9vaCkgyW_q0/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjgxODMyMjUyX20yY…
    BioPharma Dive · 1mo ago↗ source
  • As FDA misses deadline on electric shock ban, disability advocates speak out
    The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual disabilities.
    STAT · 1mo ago↗ source
  • STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United
    We've been asking Medicare for weeks about the cost of giving seniors $50 obesity drugs.
    STAT · 1mo ago↗ source